ACUTE MYELOID LEUKEMIAS
Clinical trials for ACUTE MYELOID LEUKEMIAS explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIAS trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets tough leukemia genes in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called SNDX-5613 combined with strong chemotherapy for people newly diagnosed with acute myeloid leukemia (AML) that has specific genetic changes. The main goals are to check safety and find the best dose. About 76 adults with KMT2A, NPM1, …
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE1 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:38 UTC
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML) who have run out of standard treatments. The main goals are to find a safe dose and check for side effects. About 105 participant…
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 08:36 UTC
-
New hope for leukemia patients: targeted drug combo shows promise
Disease control Recruiting nowThis study tests whether adding a new drug called revumenib to standard chemotherapy helps people with a specific genetic type of acute myeloid leukemia (AML). About 468 newly diagnosed patients will receive either revumenib plus chemo or a placebo plus chemo. The goal is to see …
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE3 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:52 UTC